AzTrials
AzTrials

Gastric EmptyingNCT06195488

Gastric Ultrasound in Diabetic Patients

An observational study of Gastric Emptying and Diabetes, run by Zonguldak Bulent Ecevit University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The American Society of Anesthesiologists (ASA) does not specify a fasting period for patients with certain comorbidities, such as diabetes, for elective surgery, and does not make a separate recommendation for surgery. Read more about this study

Who is it for?
Ages 40 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Gastric Emptying, Diabetes, Ultrasound
What is being tested?
Gastric ultrasound
Type of treatment
Surgery or procedure
How many people
1 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Oct 2022to 1 Jan 2025
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Diabetic and non-diabetic patients aged 40-65 years undergoing ASA I-III elective surgery

Who may be able to join

  • Written informed consent obtained 40-65 BMI<40 ASA I-III Fasting for at least 8 hours Elective surgery

Who cannot join

  • Pregnancy Upper gastrointestinal malignancy Large Hiatal Hernia Kidney failure Liver failure Opioid use Use of drugs affecting motility Previous upper abdominal surgery BMI ≥40 kg/m2 Emergency surgery Diabetic ketoacidosis Sepsis

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Zonguldak Bülent Ecevit University Medicine Faculty

    Zonguldak, Kozlu, 67600

Other trials in Turkey (Türkiye)

About this study

Official title: Preoperative Evaluation of Gastric Contents in Diabetic Patients With Gastric Ultrasound

The American Society of Anesthesiologists (ASA) does not specify a fasting period for patients with certain comorbidities, such as diabetes, for elective surgery, and does not make a separate recommendation for surgery.

The European Society of Anesthesiology (ESA) guidelines do not differentiate between diabetic patients and normal patients. Aspiration of gastric contents is a common cause of perioperative morbidity and mortality.

Read more

Aspiration can cause hypoxia, bronchospasm, pneumonia, acute respiratory distress syndrome and death.

The presence of food or fluid in the stomach before induction of anesthesia is one of the greatest risk factors for perioperative pulmonary aspiration. Sedation and general anesthesia suppress or inhibit physiologic mechanisms (tone of the lower esophageal sphincter and upper airway reflexes) that protect against aspiration.

Because restriction of fluid and food intake before general anesthesia is vital for patient safety, Anesthesiology societies have developed guidelines for preoperative fasting.

Current ASA guidelines recommend at least 2 hours fasting for clear liquids, 6 hours fasting after a light meal (toast and clear liquids) and 8 hours fasting after a high calorie or fat meal. The information obtained from gastric ultrasound allows anesthesiologists to determine the optimal timing of procedures, type of anesthesia and airway management technique.

Being tested
Gastric ultrasound
Keywords
fasting, gastric ultrasound, preoperative fasting, diabetes
Medical subject headings
Diabetes Mellitus, Fasting

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Gastric ultrasoundProcedure or surgery

    performing gastric ultrasound to determine gastric contents

Study groups in NCT06195488
Study groupRoleWhat they receive
Group DGroup Diabetic
Receives: Procedure: Gastric ultrasound
Group ControlNon-diabetic patients
Receives: Procedure: Gastric ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. determine stomach fullness

    To evaluate residual gastric volume in diabetic patients fasting for elective surgery

    Measured: baseline (before intubation)

Secondary outcomes (1)
  1. Incidence of risk factors

    Investigating risk factors for a full stomach in diabetic patients

    Measured: during surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jan 2024
  2. Study start15 Oct 2022
  3. Primary completion31 Oct 2024
  4. Study completion1 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT06195488
Sponsor's protocol ID
2022/17-1
Status last verified
May 2025
First submitted
24 Nov 2023
Last updated
22 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bayram MG, Incegul BGK, Baytar MS, Baytar C, Bollucuoglu K, Okyay RD, Seker DF, Piskin O, Ayoglu H. Preoperative ultrasound assessment of gastric volume in diabetic patients scheduled for elective surgery: a prospective, observational, comparative cohort study. BMC Anesthesiol. 2026 Jul 29;26(1):636. doi: 10.1186/s12871-026-04132-z.

    PubMed 42928115

Questions about this trial

What is this clinical trial studying?

An observational study of Gastric Emptying and Diabetes, run by Zonguldak Bulent Ecevit University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

determine stomach fullness (time frame: baseline (before intubation)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06195488, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in